Exploring molecular genetics of bladder cancer: lessons learned from mouse models

Area of Science:

• Oncology
• Genetics
• Molecular Biology

Background:

• Urothelial cell carcinoma (UCC) of the bladder is a prevalent malignancy with significant health impacts.
• UCC tumorigenesis follows two distinct molecular pathways: oncogenic mutations (FGFR3, HRAS) in low-grade tumors and tumor suppressor defects (p53, RB) in high-grade, invasive tumors.

Purpose of the Study:

• To review and analyze genetically engineered mouse (GEM) models of UCC developed over the past two decades.
• To assess the strengths, weaknesses, and translational potential of these GEM models.
• To highlight the role of Wnt signaling dysregulation in UCC and relevant mouse models.

Main Methods:

• Comprehensive literature review of GEM models for urothelial cell carcinoma.
• Analysis of genetic alterations and pathway dysregulation in UCC models.
• Evaluation of model fidelity to human UCC biology and therapeutic applications.

Main Results:

• Numerous GEM models targeting key oncogenes and tumor suppressors have been created for UCC research.
• These models have advanced the molecular understanding of UCC pathogenesis.
• Recent models incorporate dysregulated Wnt signaling, offering new avenues for study.

Conclusions:

• GEM models are crucial tools for dissecting UCC molecular pathways and evaluating therapeutic strategies.
• Continued development and refinement of GEM models are essential for advancing bladder cancer research and clinical translation.
• Understanding distinct tumorigenesis pathways in UCC is key to developing targeted therapies.